OBJECTIVE: To evaluate the progression of pharmacy students' knowledge of black box warnings across 3 years of didactic training, and to determine how they stay current with new warnings. METHODS: A cross-sectional survey instrument was administered to pharmacy students in their first (P1), second (P2), and third (P3) professional years. The survey assessed student awareness of medications possessing a black box warning and familiarity with the warning content for 20 medications (15 with and 5 without warnings). RESULTS: Mean number of correct responses identifying the presence or absence of a black box warning among the 20 medications were 5.8 +/- 3.3, 9.6 +/- 4.0, and 14.8 +/- 2.8 for the P1, P2, and P3 students, respectively. Knowledge of black box warning content was variable. Students were least aware of the warning content for stavudine and enoxaparin. Students were most familiar with the warning content for paroxetine and estrogen. CONCLUSION: Students' awareness and understanding of black box warnings was proportional to their educational progression, but their knowledge level was inconsistent across drug groups.
OBJECTIVE: To evaluate the progression of pharmacy students' knowledge of black box warnings across 3 years of didactic training, and to determine how they stay current with new warnings. METHODS: A cross-sectional survey instrument was administered to pharmacy students in their first (P1), second (P2), and third (P3) professional years. The survey assessed student awareness of medications possessing a black box warning and familiarity with the warning content for 20 medications (15 with and 5 without warnings). RESULTS: Mean number of correct responses identifying the presence or absence of a black box warning among the 20 medications were 5.8 +/- 3.3, 9.6 +/- 4.0, and 14.8 +/- 2.8 for the P1, P2, and P3 students, respectively. Knowledge of black box warning content was variable. Students were least aware of the warning content for stavudine and enoxaparin. Students were most familiar with the warning content for paroxetine and estrogen. CONCLUSION: Students' awareness and understanding of black box warnings was proportional to their educational progression, but their knowledge level was inconsistent across drug groups.
Entities:
Keywords:
adverse drug effects; black box warning; package insert; pharmacy students; product label
Authors: Karen E Lasser; Paul D Allen; Steffie J Woolhandler; David U Himmelstein; Sidney M Wolfe; David H Bor Journal: JAMA Date: 2002-05-01 Impact factor: 56.272
Authors: Jeff Jianfei Guo; Suellen Curkendall; Judith K Jones; Daniel Fife; Earl Goehring; Dewei She Journal: Pharmacoepidemiol Drug Saf Date: 2003-06 Impact factor: 2.890
Authors: Anita K Wagner; K Arnold Chan; Inna Dashevsky; Marsha A Raebel; Susan E Andrade; Jennifer Elston Lafata; Robert L Davis; Jerry H Gurwitz; Stephen B Soumerai; Richard Platt Journal: Pharmacoepidemiol Drug Saf Date: 2006-06 Impact factor: 2.890
Authors: W Smalley; D Shatin; D K Wysowski; J Gurwitz; S E Andrade; M Goodman; K A Chan; R Platt; S D Schech; W A Ray Journal: JAMA Date: 2000-12-20 Impact factor: 56.272
Authors: Robert J Cluxton; Zili Li; Pamela C Heaton; Sheila R Weiss; Ilene H Zuckerman; Charles J Moomaw; Van Doren Hsu; Evelyn M Rodriguez Journal: Pharmacoepidemiol Drug Saf Date: 2005-01 Impact factor: 2.890
Authors: Tauqeer Hussain Mallhi; Abdullah Salah Alanazi; Yusra Habib Khan; Nasser Hadal Alotaibi; Muhammad Salman; Abdulaziz Ibrahim Alzarea; Salah-Ud-Din Khan; Nabil K Alruwaili; Alaa Salah Alenazi; Ahmed D Alatawi; Zafar Iqbal; Muhammad Hammad Butt; Muhammad Shahid Iqbal Journal: Front Med (Lausanne) Date: 2022-04-29